“We are a wound and skin-care company that focusses on innovation, effectiveness and well-being of humans as well as our planet,\u201d says Chris Lee, Director of Microderm Technologies Ltd, a company that\u2019s making news in Hong Kong, in health circles.<\/p>\n\n\n\n
\u201cI have successfully acquired the exclusive right to use the Microcyn Technology through out Asia since 2011. We are now distributing the technology under my own brand called Dermodacyn in over 10 countries including HK, China, Australia, Japan, Philippine, South Korea and expanding. As I have been in the manufacturing and brand managing business for over 20 years, it is upmost important to establish relationship.\u201d<\/p>\n\n\n\n
Dermodacyn is a line of wound care, skin care and disinfectants that repair human cells using not just natural ingredients. In fact all the ingredients can be found from our body so it will provide the most natural healing process and enable us to defend ourselves from the harmful environment that we living in today.\u201d<\/p>\n\n\n\n
Why is this so important? \u201cBecause,\u201d says Lee, \u201cour industry now is at cross roads because of new technology, innovation and new medical breakthrough which in a way is very good for all of us to get better and lowest cost treatment.<\/p>\n\n\n\n
Unfortunately the governing bodies are overwhelmed by new products and claims coming out all the time and often you hear news of products been recalled after people report being hurt or in some cases die. Therefore it is important for my company to ensure all our product lines are effective and we have gone through over 30 clinical trials, 17 FDA and 20 CE making sure all our products are safe.\u201d<\/p>\n\n\n\n